MIRM CIK: 1759425

Mirum Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−133
FY22:
−120
FY23:
−70.9
FY24:
10.3
FY25:
55.8
Change from FY21 to FY25
millions USD
FY21:
48.5
FY22:
7.70
FY23:
−107
FY24:
−90.1
FY25:
−24.0
Change from FY21 to FY25
millions USD
FY21:
73.5
FY22:
109
FY23:
337
FY24:
17.7
FY25:
40.1
millions USD
FY21:
−10.7
FY22:
−3.34
FY23:
158
FY24:
−63.4
FY25:
75.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−133
FY22:
−120
FY23:
−71.1
FY24:
9.33
FY25:
54.9

All amounts in millions USD Data source:SEC EDGAR